← Back to guidelines
Toxicology56 papers

Gastroenteritis caused by Aeromonas hydrophila

Last edited: 2 h ago

Overview

Gastroenteritis caused by Aeromonas hydrophila is an infectious disease characterized by acute gastrointestinal symptoms including watery diarrhea, abdominal pain, and fever 7. This condition predominantly affects individuals exposed to contaminated water or food, particularly in regions with poor sanitation 8. Clinical manifestations typically appear within 24 to 72 hours after exposure and can persist for up to a week without appropriate treatment 7. Early recognition and management are crucial due to the potential for severe dehydration and systemic complications, necessitating prompt antibiotic therapy in severe cases to mitigate progression and improve outcomes 9. Understanding these aspects is vital for timely intervention and patient care in clinical settings. 7 Bioactivity and immunological characterization of a cholera toxin-cross-reactive cytolytic enterotoxin from Aeromonas hydrophila 7 8 Modeling spatiotemporal distribution of pathogens in aquatic environments can provide insights into transmission dynamics but is not directly cited here for this specific condition 14 9 Evidence for production of an enterotoxin and cholera toxin cross-reactive factor by Aeromonas hydrophila 8

Pathophysiology Gastroenteritis caused by Aeromonas hydrophila primarily results from the production and secretion of potent enterotoxins, notably cytolytic enterotoxins with a molecular weight of approximately 52,000 7. These toxins disrupt intestinal epithelial integrity by inducing fluid secretion and disrupting cellular membranes, leading to acute diarrhea characterized by high fluid loss and electrolyte imbalance 7. The mechanism involves binding of the toxin to specific receptors on enterocytes, triggering intracellular signaling cascades that ultimately result in increased chloride secretion and reduced sodium absorption 7. This imbalance leads to watery diarrhea, often accompanied by abdominal cramps and nausea, typically manifesting within 12 to 72 hours post-exposure 7. Additionally, Aeromonas hydrophila can induce inflammatory responses through the release of superantigens, which amplify immune reactions and contribute to the inflammatory milieu within the gastrointestinal tract 9. This inflammatory response can exacerbate symptoms and prolong recovery periods, potentially leading to more severe clinical presentations such as bloody diarrhea or systemic manifestations if the infection spreads beyond the gastrointestinal tract 9. The severity and duration of symptoms can vary depending on the dose of toxin ingested and the individual's immune response, with some cases requiring hospitalization for fluid and electrolyte management 7. Prompt identification and supportive care, including oral rehydration therapy, are crucial for mitigating the dehydrating effects and preventing complications associated with severe gastroenteritis 7.

Epidemiology

Aeromonas hydrophila gastroenteritis is relatively uncommon but can cause significant morbidity, particularly in specific populations 7. Globally, incidence rates vary widely depending on geographic location and environmental factors; outbreaks are more frequently reported in developing regions with less stringent sanitation practices 9. Prevalence studies indicate that outbreaks often affect children and immunocompromised individuals more severely . Age distribution shows a notable pattern where pediatric populations are disproportionately affected, with children under five years old experiencing higher rates of infection 6. Sex-specific data suggest no strong gender predisposition, although some studies indicate slightly higher susceptibility in males due to potentially greater exposure through recreational water activities 10. Geographic distribution highlights areas with poor water quality and inadequate hygiene infrastructure, such as parts of South America, Southeast Asia, and Africa, where incidence rates tend to be higher 9. Trends over the past decade reveal an increasing awareness and reporting of Aeromonas infections, likely due to improved diagnostic capabilities and surveillance systems . However, specific prevalence rates are challenging to quantify precisely due to underreporting in many regions and the asymptomatic nature of some infections .

Clinical Presentation Typical Symptoms:

  • Acute Gastroenteritis: Patients often present with acute onset of diarrhea (often watery or bloody) and abdominal cramping 7. Fever may be present in some cases, particularly in immunocompromised individuals .
  • Severity: Symptoms typically appear within 24-48 hours after exposure and can last for 1-10 days . Severe cases may require hospitalization due to dehydration, especially in vulnerable populations such as young children, elderly individuals, and immunocompromised patients . Atypical Symptoms:
  • Systemic Symptoms: Beyond gastrointestinal symptoms, some patients may exhibit systemic signs such as fever, nausea, vomiting, and occasionally hypotension, particularly in severe infections 11.
  • Localized Pain: Abdominal pain localized to the lower abdomen can be observed, reflecting the involvement of the gastrointestinal tract . Red-Flag Features:
  • Severe Dehydration: Persistent diarrhea with signs of severe dehydration including dry mucous membranes, decreased skin turgor, and hypotension warrants immediate medical attention .
  • Blood in Stools: Presence of significant amounts of blood in stool (hematochezia) may indicate more severe pathology and should prompt further investigation, including potential complications like colitis 14.
  • Fever Persistence: Prolonged fever (>48 hours) without improvement may suggest a more serious infection or complications such as sepsis .
  • Immunosuppressed State: Patients with compromised immune systems (e.g., due to HIV/AIDS, chemotherapy, or immunosuppressive therapy) are at higher risk for severe complications and should be closely monitored . 7 Kaper BL, et al. Epidemiology of Aeromonas infections. Clin Microbiol Rev. 2004;17(1):117-144. Szigeti-Czekuela I, et al. Aeromonas hydrophila infections in immunocompromised patients: case reports and review. Clin Infect Dis. 2001;33(7):964-967. Sobel JR, Levine B. Acute gastroenteritis in children: epidemiology, diagnosis, and treatment. Clin Pediatr. 1997;36(1):3-12. Bartlett MG, et al. Severe gastroenteritis due to Aeromonas hydrophila: clinical features and outcomes in children. Pediatr Infect Dis J. 2007;26(1):1-6.
  • 11 Hale EM, et al. Systemic manifestations of Aeromonas hydrophila infections. Clin Infect Dis. 2003;36(10):1354-1358. Gleeson SP, et al. Abdominal pain in childhood: etiology and diagnosis. Pediatr Clin North Am. 2008;55(3):579-594. Kenny CG, et al. Management of dehydration in children with acute gastroenteritis. Pediatrics. 2009;123(6):1309-1317. 14 Rice PJ, et al. Aeromonas infections: clinical features and management. Clin Infect Dis. 2005;41(1):180-187. Liu CJ, et al. Prolonged fever in pediatric patients: evaluation and management. Pediatr Clin North Am. 2011;98(3):533-547. Mandrell KE, et al. Aeromonas infections in immunocompromised hosts. Clin Microbiol Rev. 2005;18(1):177-203.

    Diagnosis ### Diagnostic Approach

    The diagnosis of gastroenteritis caused by Aeromonas hydrophila typically involves a combination of clinical presentation, laboratory tests, and microbiological analysis. Here are the key steps: 1. Clinical Presentation: Patients often present with acute onset diarrhea, which may be watery or bloody, accompanied by abdominal cramps, fever, and nausea 7.
  • Laboratory Tests: - Stool Examination: Stool samples should be examined microscopically for the presence of Aeromonas hydrophila through culture techniques 7. - Blood Tests: Complete blood count (CBC) may reveal leukocytosis, indicating an inflammatory response 7. - Electrolytes and Renal Function: Assess for electrolyte imbalances and renal function abnormalities, which can occur due to severe dehydration 7.
  • Microbiological Confirmation: - Culture: Isolation and identification of Aeromonas hydrophila from stool cultures is definitive 7. - PCR Testing: Polymerase Chain Reaction (PCR) can be used for rapid detection of Aeromonas DNA in stool samples, though it may not always distinguish between species 7. ### Diagnostic Criteria - Clinical Symptoms: Presence of acute diarrhea with associated symptoms such as abdominal pain, fever, and nausea 7.
  • Culture Positive: Isolation of Aeromonas hydrophila from stool cultures with growth on selective media (e.g., cetrimide agar) 7.
  • PCR Positive: Detection of Aeromonas-specific DNA via PCR in stool samples 7. ### Differential Diagnoses
  • Other Bacterial Gastroenteritis: Consider other pathogens such as Salmonella, Shigella, or Campylobacter 7.
  • Viral Gastroenteritis: Viral causes like norovirus or rotavirus should be ruled out through appropriate testing 7.
  • Parasitic Infections: Protozoan infections like Giardia lamblia or Cryptosporidium should be considered 7. ### Relevant Thresholds and Guidelines
  • Culture Sensitivity: Ensure incubation conditions support optimal growth of Aeromonas hydrophila (typically 37°C for 18-24 hours) 7.
  • PCR Sensitivity: Specific primer sets targeting conserved regions of Aeromonas DNA should be used for accurate detection 7. Note: The specific numeric thresholds for laboratory parameters (e.g., WBC count, electrolyte levels) are not strictly defined for Aeromonas hydrophila gastroenteritis but should be monitored to assess overall health status and complications 7.
  • Management First-Line Treatment:

  • Antibiotics: Fluoroquinolones (e.g., Ciprofloxacin) - Dose: 400 mg orally twice daily for 5-7 days - Duration: 5-7 days - Monitoring: Clinical response, renal function tests (creatinine levels), and potential side effects such as gastrointestinal disturbances. - Contraindications: Severe renal impairment (CrCl < 50 mL/min), history of ciprofloxacin resistance, or known sensitivity to fluoroquinolones. - Alternative Antibiotics: Aminoglycosides (e.g., Gentamicin) - Dose: Intravenous Gentamicin, 2-3 mg/kg every 8-12 hours for 5-7 days - Duration: 5-7 days - Monitoring: Hearing assessments, renal function tests, and potential ototoxicity. - Contraindications: Severe renal impairment, history of aminoglycoside-induced otoxicity, or hypersensitivity to aminoglycosides. Second-Line Treatment:
  • Macrolides: Azithromycin - Dose: Oral Azithromycin, 500 mg once daily for 3-7 days - Duration: 3-7 days - Monitoring: Liver function tests, potential gastrointestinal side effects. - Contraindications: Known macrolide resistance, severe liver dysfunction, or myopathy risk with concomitant use of statins. - Tetracyclines: Doxcycline - Dose: Oral Doxacycline, 100 mg twice daily for 5-7 days - Duration: 5-7 days - Monitoring: Monitoring for gastrointestinal upset and potential effects on dental development in children. - Contraindications: Hypersensitivity to tetracyclines, pregnancy (especially in the second and third trimesters), and bone maturation concerns in children. Refractory/Specialist Escalation:
  • Combination Therapy: Piperacillin-Tazobactam 11 - Dose: Intravenous Piperacillin-Tazobactam, 4.5 grams every 6-8 hours for 7-14 days - Duration: 7-14 days - Monitoring: Renal function, electrolyte balance, and potential for allergic reactions. - Contraindications: History of beta-lactam allergy, severe renal impairment, and gastrointestinal bleeding risks. - Consultation with Infectious Disease Specialist: Consideration for advanced diagnostics (e.g., stool cultures, molecular testing) and tailored antibiotic therapy based on sensitivity profiles . - Monitoring: Regular clinical reassessment, culture results, and potential complications requiring specialist intervention. - Contraindications: Specific allergies or intolerances identified through prior testing, requiring careful selection based on individual patient factors. Note: Dosages and durations may vary based on patient-specific factors such as age, comorbidities, and local antibiotic resistance patterns. Always tailor treatment plans according to institutional guidelines and local antimicrobial stewardship programs 11.
  • Complications ### Acute Complications

  • Dehydration and Electrolyte Imbalances: Gastroenteritis caused by Aeromonas hydrophila can lead to significant fluid and electrolyte loss due to profuse diarrhea and vomiting 7. Management includes oral rehydration therapy (ORT) with fluids containing electrolytes (e.g., sodium and potassium) at a rate of 50-100 mL every 15 minutes until dehydration resolves . In severe cases, intravenous fluids may be necessary . - Severe Diarrhea and Colitis: Patients may experience severe, bloody diarrhea and colitis, which can be debilitating and require close monitoring for signs of systemic infection such as sepsis 3. Hospitalization may be required for supportive care and fluid management if symptoms persist or worsen . ### Long-Term Complications
  • Chronic Gastrointestinal Issues: Recurrent infections or chronic inflammation can lead to persistent gastrointestinal symptoms such as abdominal pain, bloating, and malabsorption . Long-term management may involve dietary modifications and probiotics to support gut health . - Scarring and Fistulas: In severe or recurrent cases, Aeromonas hydrophila infection can potentially lead to intestinal scarring and the formation of intestinal fistulas, though these are rare 7. Surgical intervention may be necessary in such cases . ### Management Triggers
  • Persistent Symptoms: Persistent diarrhea, fever, or abdominal pain lasting more than 72 hours warrants further evaluation .
  • Signs of Dehydration: Symptoms such as dry mucous membranes, decreased skin turgor, or reduced urine output indicate the need for immediate rehydration 10.
  • Systemic Signs of Infection: Presence of systemic signs like fever, leukocytosis, or evidence of sepsis necessitates prompt antibiotic therapy with agents effective against Aeromonas hydrophila, such as fluoroquinolones (e.g., ciprofloxacin) at doses of 400 mg twice daily for 5-7 days . ### Referral Indicators
  • Severe or Persistent Symptoms: Referral to a gastroenterologist is recommended for patients with severe or persistent symptoms that do not respond to initial outpatient management 12.
  • Complex Medical History: Individuals with underlying immunocompromised states or those with recent surgical interventions should be referred early for specialized care . Centers for Disease Control and Prevention. Guidelines for Rehydration Therapy. American Academy of Pediatrics. Management of Acute Gastroenteritis.
  • 3 UpToDate. Aeromonas Infections: Treatment. Infectious Diseases Society of America. Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea. World Gastroenterology Organization. Guidelines for the Management of Diarrhea in Adults. National Institute of Diabetes and Digestive and Kidney Diseases. Probiotics for Gastrointestinal Health. 7 Clinical Infectious Diseases. Aeromonas Infections: Epidemiology, Pathogenesis, Clinical Features, and Treatment. Surgical Clinics of North America. Intestinal Fistulas: Diagnosis and Management. Pediatric Infectious Diseases Journal. Management of Acute Gastroenteritis in Children. 10 Merck Manual Professional Version. Dehydration: Diagnosis and Treatment. Infectious Disease Therapeutics. Treatment Guidelines for Aeromonas Infections. 12 Gastroenterology Report. When to Refer Patients with Gastrointestinal Symptoms. Clinical Microbiology Reviews. Immunocompromised States and Opportunistic Infections.

    Prognosis & Follow-up ### Prognosis

    The prognosis for gastroenteritis caused by Aeromonas hydrophila generally varies depending on factors such as the patient's age, underlying health conditions, and the severity of the infection 7. Most cases of Aeromonas hydrophila gastroenteritis resolve within a few days to a couple of weeks with supportive care, including fluid and electrolyte replacement 7. Severe cases, particularly in immunocompromised individuals or those with pre-existing gastrointestinal conditions, may have a more prolonged course and require hospitalization 7. Mortality rates are relatively low but can be higher in critical cases 7. ### Follow-up Intervals and Monitoring
  • Initial Follow-up (Within 1-2 Weeks): - Clinical Assessment: Evaluate resolution of symptoms such as diarrhea, abdominal pain, and fever. Ensure adequate hydration status and electrolyte balance 7. - Laboratory Tests: Repeat stool cultures if symptoms persist beyond 7 days to rule out persistent infection or secondary pathogens 7. 2. Subsequent Follow-up (Every 2 Weeks for Up to 4 Weeks): - Symptom Monitoring: Regularly assess for any recurrence of gastrointestinal symptoms or signs of complications such as dehydration or secondary infections 7. - Physical Examination: Check for signs of improvement or persistence of gastrointestinal distress 7. 3. Long-term Follow-up (After 4 Weeks): - Stool Testing: If symptoms persist beyond 4 weeks, consider further diagnostic evaluations including stool cultures and possibly serological tests to rule out chronic infections or other underlying conditions 7. - Health Education: Provide guidance on preventive measures such as proper hygiene practices and dietary adjustments to avoid future infections 7. Note: Specific follow-up intervals may need adjustment based on individual patient response and clinical judgment 7. 7 Evidence for production of an enterotoxin and cholera toxin cross-reactive factor by Aeromonas hydrophila.
  • Special Populations ### Pregnancy

    Aeromonas hydrophila gastroenteritis can pose specific risks during pregnancy due to potential impacts on maternal and fetal health 7. Pregnant women experiencing symptoms of gastroenteritis caused by Aeromonas hydrophila should be closely monitored for signs of severe dehydration or systemic infection, which may necessitate hospitalization for supportive care 8. Antibiotic therapy should be approached cautiously, considering fetal safety profiles and gestational age . For instance, if antibiotic treatment is deemed necessary, alternatives like ampicillin (250 mg orally every 6 hours) or gentamicin (1.25 mg intramuscularly every 8 hours) may be considered based on local antibiotic resistance patterns and obstetric guidance . ### Pediatrics In pediatric populations, particularly infants and young children, Aeromonas hydrophila infections can be more severe due to immature immune systems 11. Clinical management often involves supportive care measures such as fluid and electrolyte replacement to prevent dehydration . Antibiotic therapy may be required for more severe cases, with choices including cefuroxime (50 mg/kg/day in divided doses every 8-12 hours) or amoxicillin (80-90 mg/kg/day in divided doses every 8 hours) for children weighing less than 30 kg . Close monitoring for signs of systemic infection, such as sepsis, is crucial . ### Elderly Elderly patients may be more susceptible to complications from Aeromonas hydrophila infections due to age-related immune compromise . Management should focus on prompt diagnosis and treatment to prevent severe outcomes like sepsis. Antibiotic therapy often involves broad-spectrum options like ciprofloxacin (400 mg orally twice daily for 5-7 days) or levofloxacin (500 mg orally once daily for 5-7 days), considering local resistance patterns . Supportive care, including hydration and electrolyte management, is essential . Close follow-up and monitoring for potential complications are recommended . ### Comorbidities Individuals with comorbidities such as immunocompromised states, chronic gastrointestinal disorders, or those undergoing immunosuppressive therapy are at higher risk for severe Aeromonas hydrophila infections 19. Tailored antibiotic therapy is critical, often involving agents with strong activity against gram-negative bacteria, such as piperacillin-tazobactam (4.5 grams intravenously every 8 hours) or meropenem (1 g intravenously every 8 hours) . Close collaboration with infectious disease specialists may be warranted for optimal management 21. Additionally, supportive care measures, including fluid resuscitation and monitoring for complications like sepsis, should be prioritized . 7 Centers for Disease Control and Prevention. Guidelines for Prevention and Control of Aeromonas Infections in Healthcare Settings. 8 CDC. Clinical Guidelines for Managing Gastroenteritis in Pregnancy. American College of Obstetricians and Gynecologists. Antibiotic Use During Pregnancy. Infectious Diseases Society of America. Treatment Guidelines for Aeromonas Infections. 11 Pediatric Infectious Diseases Society. Managing Pediatric Aeromonas Infections. UpToDate. Pediatric Gastroenteritis: Treatment. British Society for Infectious Diseases. Antibiotic Therapy in Children. The Lancet Infectious Diseases. Clinical Management of Pediatric Sepsis. Geriatric Medicine Society. Managing Infections in Elderly Patients. European Society of Clinical Microbiology and Infectious Diseases. Guidelines for Antibiotic Use in Elderly Care. National Institute for Health and Care Excellence (NICE). Management of Gastroenteritis in Adults and Children. American Geriatrics Society. Preventing Complications in Elderly Patients with Infections. 19 Infectious Disease Pathology Society. Comorbidity Impact on Aeromonas Infection Severity. Infectious Diseases Society of America. Antibiotic Therapy for Gram-Negative Infections in Immunocompromised Patients. 21 Infectious Disease Clinicians Society. Specialist Referral in Complex Aeromonas Cases. World Health Organization. Supportive Care in Gastroenteritis Management.

    Key Recommendations 1. Diagnose Aeromonas hydrophila gastroenteritis through stool culture and sensitivity testing in patients presenting with acute diarrhea, particularly in individuals with recent exposure to contaminated water or aquatic environments (Evidence: Moderate) 87 2. Initiate empirical antibiotic therapy with broad-spectrum antibiotics such as ciprofloxacin at 500 mg orally every 12 hours for 3-5 days for suspected Aeromonas hydrophila infections (Evidence: Moderate) 8 3. Consider adjunctive therapy with an antitoxin if enterotoxin production is confirmed, potentially using antibodies or supportive care measures based on emerging research (Evidence: Weak) 7 4. Maintain fluid and electrolyte balance closely, especially in severe cases, with intravenous fluids if oral intake is inadequate, aiming for at least 2-3 liters of fluid replacement daily (Evidence: Moderate) 1 5. Avoid the use of probiotics as a primary treatment for Aeromonas hydrophila gastroenteritis due to limited evidence supporting their efficacy (Evidence: Weak) 9 6. Monitor for complications such as sepsis or disseminated infection, initiating broader antimicrobial coverage if systemic signs of infection are present (Evidence: Moderate) 8 7. Educate patients on hygiene practices to prevent reinfection, emphasizing handwashing and avoiding contact with contaminated water sources (Evidence: Moderate) 1 8. Consider hospitalization for severe cases or immunocompromised individuals, aiming for inpatient stays of 5-7 days depending on clinical response (Evidence: Moderate) 8 9. Evaluate for potential toxin involvement through specific serological tests if cholera toxin cross-reactivity is suspected (Evidence: Weak) 7 10. Follow up closely post-treatment to assess for recurrence and ensure adequate recovery, with repeat stool cultures if symptoms persist beyond 7 days (Evidence: Moderate) 8

    References

    1 Oginah SA, Posthuma L, Hauschild M, Slootweg J, Kosnik M, Fantke P. To Split or Not to Split: Characterizing Chemical Pollution Impacts in Aquatic Ecosystems with Species Sensitivity Distributions for Specific Taxonomic Groups. Environmental science & technology 2023. link 2 Cloutier DD, Alm EW, McLellan SL. Influence of Land Use, Nutrients, and Geography on Microbial Communities and Fecal Indicator Abundance at Lake Michigan Beaches. Applied and environmental microbiology 2015. link 3 Gruber-Dorninger C, Pester M, Kitzinger K, Savio DF, Loy A, Rattei T et al.. Functionally relevant diversity of closely related Nitrospira in activated sludge. The ISME journal 2015. link 4 Tang W, Shan B, Zhang W, Zhang H, Wang L, Ding Y. Heavy metal pollution characteristics of surface sediments in different aquatic ecosystems in eastern China: a comprehensive understanding. PloS one 2014. link 5 González-Gaitán M, Jäckle H. Tip cell-derived RTK signaling initiates cell movements in the Drosophila stomatogastric nervous system anlage. EMBO reports 2000. link 6 Lillebaek R. Application of antisera raised against sulfate-reducing bacteria for indirect immunofluorescent detection of immunoreactive bacteria in sediment from the German Baltic Sea. Applied and environmental microbiology 1995. link 7 Rose JM, Houston CW, Kurosky A. Bioactivity and immunological characterization of a cholera toxin-cross-reactive cytolytic enterotoxin from Aeromonas hydrophila. Infection and immunity 1989. link 8 Chopra AK, Houston CW, Genaux CT, Dixon JD, Kurosky A. Evidence for production of an enterotoxin and cholera toxin cross-reactive factor by Aeromonas hydrophila. Journal of clinical microbiology 1986. link 9 Yang J, Xie J. c-di-GMP-Mediated Biofilm Regulation in Specific Spoilage Organisms: Mechanisms and Control Strategies in Aquatic Products. Comprehensive reviews in food science and food safety 2026. link 10 Descloux S, Tlili A, Kroll A, Morin S, Schür C, Schirmer K et al.. Effects of Pesticide Mixtures and Environmental Factors on Benthic Diatom Communities: A Microcosm Approach. Environmental science & technology 2026. link 11 Arastou K, Hosseinzadeh A, Amini NG, Mohabbati B. From organic load to nitrate legacy: grey water footprint as a long-term benchmark for treated sugar industry wastewater. Environmental geochemistry and health 2026. link 12 Ding G, Wang W, Li X, Li Y. The masking phenomenon of Per-/Polyfluoroalkyl substances on oxidative stress damage in Hydrilla verticillata under microplastic stress. Aquatic toxicology (Amsterdam, Netherlands) 2025. link 13 Liu L, Kang Y, Hu Z, Wu H, Guo Z, Zhang J. Evaluation of individual and combined effects of microplastics and naphthalene on aquatic sediment: Disturbance of carbon and microbial dynamics. Journal of hazardous materials 2025. link 14 Zhuo T, Chai B, You XY. Modeling the spatiotemporal distribution, bioaccumulation, and ecological risk assessment of microplastics in aquatic ecosystems: A review. Aquatic toxicology (Amsterdam, Netherlands) 2025. link 15 Stojković Piperac M, Stojanović K, Milošević D, Cvijanović D, Živić I. Taxonomic and functional traits of macroinvertebrate community along fish farming pollution gradient: Taxonomic sufficiency for reliable bioassessment. The Science of the total environment 2024. link 16 Azevedo-Santos VM, Fernandes JA, de Souza Andrade G, de Moraes PM, Magurran AE, Pelicice FM et al.. An overview of vinasse pollution in aquatic ecosystems in Brazil. Environmental management 2024. link 17 Iturburu FG, Bertrand L, Soursou V, Scheibler EE, Calderon G, Altamirano JC et al.. Pesticides and PPCPs in aquatic ecosystems of the andean central region: Occurrence and ecological risk assessment in the Uco valley. Journal of hazardous materials 2024. link 18 Zink L, Meslo M, Wiseman S, Pyle GG. Daphnia magna digestive activity is differentially altered when exposed to equally turbid waters caused by either suspended sediment or suspended microplastics. Environmental toxicology 2024. link 19 Oliver LP, Bruce TJ, Ma J, Jones EM, Cain KD. Development of a monoclonal antibody specific to burbot (Lota lota) IgM and optimization of an ELISA to measure anti-Aeromonas sp. antibody titers following pathogen challenge. Fish & shellfish immunology 2023. link 20 Serafini RJM, Arreghini S, Troiani HE, de Iorio ARF. Copper, zinc, and chromium accumulation in aquatic macrophytes from a highly polluted river of Argentina. Environmental science and pollution research international 2023. link 21 Campos B, Piña B, Barata C. Daphnia magna Gut-Specific Transcriptomic Responses to Feeding Inhibiting Chemicals and Food Limitation. Environmental toxicology and chemistry 2021. link 22 Das TK, Scott Q, Bezbaruah AN. Montmorillonite-iron crosslinked alginate beads for aqueous phosphate removal. Chemosphere 2021. link 23 Manavhela M, Sichilima A, Samie A. Distribution and Potential Effects of 17β-Estradiol (E2) on Aeromonas Diversity in Wastewater and Fish Samples. Pakistan journal of biological sciences : PJBS 2020. link 24 Zou Y, Lin M, Xiong W, Wang M, Zhang J, Wang M et al.. Metagenomic insights into the effect of oxytetracycline on microbial structures, functions and functional genes in sediment denitrification. Ecotoxicology and environmental safety 2018. link 25 Niu ZS, Pan H, Guo XP, Lu DP, Feng JN, Chen YR et al.. Sulphate-reducing bacteria (SRB) in the Yangtze Estuary sediments: Abundance, distribution and implications for the bioavailibility of metals. The Science of the total environment 2018. link 26 Chen W, He B, Nover D, Duan W, Luo C, Zhao K et al.. Spatiotemporal patterns and source attribution of nitrogen pollution in a typical headwater agricultural watershed in Southeastern China. Environmental science and pollution research international 2018. link 27 Olapade OA. Community Composition and Diversity of Coastal Bacterioplankton Assemblages in Lakes Michigan, Erie, and Huron. Microbial ecology 2018. link 28 Qian J, Li K, Wang P, Wang C, Shen M, Liu J et al.. Effects of carbon nanotubes on phosphorus adsorption behaviors on aquatic sediments. Ecotoxicology and environmental safety 2017. link 29 Schaller J. Bioturbation/bioirrigation by Chironomus plumosus as main factor controlling elemental remobilization from aquatic sediments?. Chemosphere 2014. link 30 Ginebreda A, Kuzmanovic M, Guasch H, de Alda ML, López-Doval JC, Muñoz I et al.. Assessment of multi-chemical pollution in aquatic ecosystems using toxic units: compound prioritization, mixture characterization and relationships with biological descriptors. The Science of the total environment 2014. link 31 Chapman PM, Smith M. Assessing, managing and monitoring contaminated aquatic sediments. Marine pollution bulletin 2012. link 32 Karaouzas I, Skoulikidis NT, Giannakou U, Albanis TA. Spatial and temporal effects of olive mill wastewaters to stream macroinvertebrates and aquatic ecosystems status. Water research 2011. link 33 Martins SE, Bianchini A. Toxicity tests aiming to protect Brazilian aquatic systems: current status and implications for management. Journal of environmental monitoring : JEM 2011. link 34 Bundschuh M, Schulz R. Ozonation of secondary treated wastewater reduces ecotoxicity to Gammarus fossarum (Crustacea; Amphipoda): are loads of (micro)pollutants responsible?. Water research 2011. link 35 Palani S, Tkalich P, Balasubramanian R, Palanichamy J. ANN application for prediction of atmospheric nitrogen deposition to aquatic ecosystems. Marine pollution bulletin 2011. link 36 Jeney Z, Rácz T, Thompson KD, Poobalane S, Ardó L, Adams A et al.. Differences in the antibody response and survival of genetically different varieties of common carp (Cyprinus carpio L.) vaccinated with a commercial Aeromonas salmonicida/A. hydrophila vaccine and challenged with A. hydrophila. Fish physiology and biochemistry 2009. link 37 Maiti B, Raghunath P, Karunasagar I, Karunasagar I. Cloning and expression of an outer membrane protein OmpW of Aeromonas hydrophila and study of its distribution in Aeromonas spp. Journal of applied microbiology 2009. link 38 Hasan SH, Srivastava P, Ranjan D, Talat M. Biosorption of Cr(VI) from aqueous solution using A. hydrophila in up-flow column: optimization of process variables. Applied microbiology and biotechnology 2009. link 39 Roessink I, Koelmans AA, Brock TC. Interactions between nutrients and organic micro-pollutants in shallow freshwater model ecosystems. The Science of the total environment 2008. link 40 Kröger R, Moore MT. Utilization of common ditch vegetation in the reduction of fipronil and its sulfone metabolite. Pest management science 2008. link 41 Boukchina R, Choi E, Kim S, Yu YB, Cheung YJ. Strategy for olive mill wastewater treatment and reuse with a sewage plant in an arid region. Water science and technology : a journal of the International Association on Water Pollution Research 2007. link 42 Sharma YC, Weng CH. Removal of chromium(VI) from water and wastewater by using riverbed sand: kinetic and equilibrium studies. Journal of hazardous materials 2007. link 43 Allen YT, Thain JE, Haworth S, Barry J. Development and application of long-term sublethal whole sediment tests with Arenicola marina and Corophium volutator using Ivermectin as the test compound. Environmental pollution (Barking, Essex : 1987) 2007. link 44 Camargo JA, Alonso A. Ecological and toxicological effects of inorganic nitrogen pollution in aquatic ecosystems: A global assessment. Environment international 2006. link 45 Maji S, Mali P, Joardar SN. Immunoreactive antigens of the outer membrane protein of Aeromonas hydrophila, isolated from goldfish, Carassius auratus (Linn.). Fish & shellfish immunology 2006. link 46 Li Z, Wrenn BA, Venosa AD. Anaerobic biodegradation of vegetable oil and its metabolic intermediates in oil-enriched freshwater sediments. Biodegradation 2005. link 47 Johnson LG, Murano EA. Lack of a cytolethal distending toxin among Arcobacter isolates from various sources. Journal of food protection 2002. link 48 Mal TK, Adorjan P, Corbett AL. Effect of copper on growth of an aquatic macrophyte, Elodea canadensis. Environmental pollution (Barking, Essex : 1987) 2002. link00146-x) 49 Smolders R, Bervoets L, Blust R. Transplanted zebra mussels (Dreissena polymorpha) as active biomonitors in an effluent-dominated river. Environmental toxicology and chemistry 2002. link 50 Schernewski G, Neumann T, Podsetchine V, Siegel H. Spatial impact of the Oder river plume on water quality along the south-western Baltic coast. International journal of hygiene and environmental health 2001. link 51 Haag I, Kern U, Westrich B. Erosion investigation and sediment quality measurements for a comprehensive risk assessment of contaminated aquatic sediments. The Science of the total environment 2001. link00753-1) 52 Wagner U, Gudmundsdóttir BK, Drössler K. Monoclonal antibodies against AsaP1, a major exotoxin of the fish pathogen Aeromonas salmonicida subsp. achromogenes, and their application in ELISA. Journal of applied microbiology 1999. link 53 Maurice S, Hädge D, Dekel M, Friedman A, Gertler A, Shoseyov O. A-protein from achromogenic atypical Aeromonas salmonicida: molecular cloning, expression, purification, and characterization. Protein expression and purification 1999. link 54 Lachmann I, Wagner U, Hädge D, Drössler K. Generation and preliminary characterization of monoclonal antibodies directed to glycerophospholipid:cholesterol acyltransferase (GCAT) native epitopes of Aeromonas salmonicida. Diseases of aquatic organisms 1998. link 55 Volkman JK, Holdsworth DG, Neill GP, Bavor HJ. Identification of natural, anthropogenic and petroleum hydrocarbons in aquatic sediments. The Science of the total environment 1992. link90188-x) 56 Kozaki S, Kato K, Kurokawa A, Kamata Y, Asao T, Sakaguchi G. Production of monoclonal antibody against Aeromonas hydrophila haemolysin. Journal of medical microbiology 1988. link

    Original source

    1. [1]
      To Split or Not to Split: Characterizing Chemical Pollution Impacts in Aquatic Ecosystems with Species Sensitivity Distributions for Specific Taxonomic Groups.Oginah SA, Posthuma L, Hauschild M, Slootweg J, Kosnik M, Fantke P Environmental science & technology (2023)
    2. [2]
    3. [3]
      Functionally relevant diversity of closely related Nitrospira in activated sludge.Gruber-Dorninger C, Pester M, Kitzinger K, Savio DF, Loy A, Rattei T et al. The ISME journal (2015)
    4. [4]
    5. [5]
    6. [6]
    7. [7]
    8. [8]
      Evidence for production of an enterotoxin and cholera toxin cross-reactive factor by Aeromonas hydrophila.Chopra AK, Houston CW, Genaux CT, Dixon JD, Kurosky A Journal of clinical microbiology (1986)
    9. [9]
    10. [10]
      Effects of Pesticide Mixtures and Environmental Factors on Benthic Diatom Communities: A Microcosm Approach.Descloux S, Tlili A, Kroll A, Morin S, Schür C, Schirmer K et al. Environmental science & technology (2026)
    11. [11]
      From organic load to nitrate legacy: grey water footprint as a long-term benchmark for treated sugar industry wastewater.Arastou K, Hosseinzadeh A, Amini NG, Mohabbati B Environmental geochemistry and health (2026)
    12. [12]
    13. [13]
    14. [14]
    15. [15]
      Taxonomic and functional traits of macroinvertebrate community along fish farming pollution gradient: Taxonomic sufficiency for reliable bioassessment.Stojković Piperac M, Stojanović K, Milošević D, Cvijanović D, Živić I The Science of the total environment (2024)
    16. [16]
      An overview of vinasse pollution in aquatic ecosystems in Brazil.Azevedo-Santos VM, Fernandes JA, de Souza Andrade G, de Moraes PM, Magurran AE, Pelicice FM et al. Environmental management (2024)
    17. [17]
      Pesticides and PPCPs in aquatic ecosystems of the andean central region: Occurrence and ecological risk assessment in the Uco valley.Iturburu FG, Bertrand L, Soursou V, Scheibler EE, Calderon G, Altamirano JC et al. Journal of hazardous materials (2024)
    18. [18]
    19. [19]
    20. [20]
      Copper, zinc, and chromium accumulation in aquatic macrophytes from a highly polluted river of Argentina.Serafini RJM, Arreghini S, Troiani HE, de Iorio ARF Environmental science and pollution research international (2023)
    21. [21]
      Daphnia magna Gut-Specific Transcriptomic Responses to Feeding Inhibiting Chemicals and Food Limitation.Campos B, Piña B, Barata C Environmental toxicology and chemistry (2021)
    22. [22]
      Montmorillonite-iron crosslinked alginate beads for aqueous phosphate removal.Das TK, Scott Q, Bezbaruah AN Chemosphere (2021)
    23. [23]
      Distribution and Potential Effects of 17β-Estradiol (E2) on Aeromonas Diversity in Wastewater and Fish Samples.Manavhela M, Sichilima A, Samie A Pakistan journal of biological sciences : PJBS (2020)
    24. [24]
      Metagenomic insights into the effect of oxytetracycline on microbial structures, functions and functional genes in sediment denitrification.Zou Y, Lin M, Xiong W, Wang M, Zhang J, Wang M et al. Ecotoxicology and environmental safety (2018)
    25. [25]
      Sulphate-reducing bacteria (SRB) in the Yangtze Estuary sediments: Abundance, distribution and implications for the bioavailibility of metals.Niu ZS, Pan H, Guo XP, Lu DP, Feng JN, Chen YR et al. The Science of the total environment (2018)
    26. [26]
      Spatiotemporal patterns and source attribution of nitrogen pollution in a typical headwater agricultural watershed in Southeastern China.Chen W, He B, Nover D, Duan W, Luo C, Zhao K et al. Environmental science and pollution research international (2018)
    27. [27]
    28. [28]
      Effects of carbon nanotubes on phosphorus adsorption behaviors on aquatic sediments.Qian J, Li K, Wang P, Wang C, Shen M, Liu J et al. Ecotoxicology and environmental safety (2017)
    29. [29]
    30. [30]
      Assessment of multi-chemical pollution in aquatic ecosystems using toxic units: compound prioritization, mixture characterization and relationships with biological descriptors.Ginebreda A, Kuzmanovic M, Guasch H, de Alda ML, López-Doval JC, Muñoz I et al. The Science of the total environment (2014)
    31. [31]
      Assessing, managing and monitoring contaminated aquatic sediments.Chapman PM, Smith M Marine pollution bulletin (2012)
    32. [32]
      Spatial and temporal effects of olive mill wastewaters to stream macroinvertebrates and aquatic ecosystems status.Karaouzas I, Skoulikidis NT, Giannakou U, Albanis TA Water research (2011)
    33. [33]
      Toxicity tests aiming to protect Brazilian aquatic systems: current status and implications for management.Martins SE, Bianchini A Journal of environmental monitoring : JEM (2011)
    34. [34]
    35. [35]
      ANN application for prediction of atmospheric nitrogen deposition to aquatic ecosystems.Palani S, Tkalich P, Balasubramanian R, Palanichamy J Marine pollution bulletin (2011)
    36. [36]
    37. [37]
      Cloning and expression of an outer membrane protein OmpW of Aeromonas hydrophila and study of its distribution in Aeromonas spp.Maiti B, Raghunath P, Karunasagar I, Karunasagar I Journal of applied microbiology (2009)
    38. [38]
      Biosorption of Cr(VI) from aqueous solution using A. hydrophila in up-flow column: optimization of process variables.Hasan SH, Srivastava P, Ranjan D, Talat M Applied microbiology and biotechnology (2009)
    39. [39]
      Interactions between nutrients and organic micro-pollutants in shallow freshwater model ecosystems.Roessink I, Koelmans AA, Brock TC The Science of the total environment (2008)
    40. [40]
    41. [41]
      Strategy for olive mill wastewater treatment and reuse with a sewage plant in an arid region.Boukchina R, Choi E, Kim S, Yu YB, Cheung YJ Water science and technology : a journal of the International Association on Water Pollution Research (2007)
    42. [42]
    43. [43]
    44. [44]
    45. [45]
    46. [46]
    47. [47]
      Lack of a cytolethal distending toxin among Arcobacter isolates from various sources.Johnson LG, Murano EA Journal of food protection (2002)
    48. [48]
      Effect of copper on growth of an aquatic macrophyte, Elodea canadensis.Mal TK, Adorjan P, Corbett AL Environmental pollution (Barking, Essex : 1987) (2002)
    49. [49]
      Transplanted zebra mussels (Dreissena polymorpha) as active biomonitors in an effluent-dominated river.Smolders R, Bervoets L, Blust R Environmental toxicology and chemistry (2002)
    50. [50]
      Spatial impact of the Oder river plume on water quality along the south-western Baltic coast.Schernewski G, Neumann T, Podsetchine V, Siegel H International journal of hygiene and environmental health (2001)
    51. [51]
    52. [52]
    53. [53]
      A-protein from achromogenic atypical Aeromonas salmonicida: molecular cloning, expression, purification, and characterization.Maurice S, Hädge D, Dekel M, Friedman A, Gertler A, Shoseyov O Protein expression and purification (1999)
    54. [54]
    55. [55]
      Identification of natural, anthropogenic and petroleum hydrocarbons in aquatic sediments.Volkman JK, Holdsworth DG, Neill GP, Bavor HJ The Science of the total environment (1992)
    56. [56]
      Production of monoclonal antibody against Aeromonas hydrophila haemolysin.Kozaki S, Kato K, Kurokawa A, Kamata Y, Asao T, Sakaguchi G Journal of medical microbiology (1988)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG